Literature DB >> 25979574

Comment on: Wollmer P, Engström G. Fixed ratio or lower limit of normal (LLN) as cut-off value for FEV1/VC: An outcome study. Respiratory Medicine (2013) 107, 1460-1462.: Fixed ratio or lower limit of normal (LLN) as cut-off value for FEV1/VC.

Carlos A Vaz Fragoso1, Jeffrey J Pretto2, Philip H Quanjer3.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25979574      PMCID: PMC5287365          DOI: 10.1016/j.rmed.2013.09.024

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  13 in total

1.  Lung function and risk of myocardial infarction and sudden cardiac death.

Authors:  G D Friedman; A L Klatsky; A B Siegelaub
Journal:  N Engl J Med       Date:  1976-05-13       Impact factor: 91.245

2.  Reference ranges for spirometry across all ages: a new approach.

Authors:  Sanja Stanojevic; Angie Wade; Janet Stocks; John Hankinson; Allan L Coates; Huiqi Pan; Mark Rosenthal; Mary Corey; Patrick Lebecque; Tim J Cole
Journal:  Am J Respir Crit Care Med       Date:  2007-11-15       Impact factor: 21.405

3.  Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study.

Authors:  Anne Stephenson; Dallas Seitz; Chaim M Bell; Andrea Gruneir; Andrea S Gershon; Peter C Austin; Longdi Fu; Geoffrey M Anderson; Paula A Rochon; Sudeep S Gill
Journal:  Arch Intern Med       Date:  2011-05-23

4.  Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality.

Authors:  H M Lee; H Le; B T Lee; V A Lopez; N D Wong
Journal:  Eur Respir J       Date:  2010-06-18       Impact factor: 16.671

5.  Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Carolyn L Rochester; H Klar Yaggi; Thomas M Gill
Journal:  Respir Med       Date:  2010-03-03       Impact factor: 3.415

Review 6.  Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Sonal Singh; Yoon K Loke; Curt D Furberg
Journal:  JAMA       Date:  2008-09-24       Impact factor: 56.272

7.  Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.

Authors:  Philip H Quanjer; Sanja Stanojevic; Tim J Cole; Xaver Baur; Graham L Hall; Bruce H Culver; Paul L Enright; John L Hankinson; Mary S M Ip; Jinping Zheng; Janet Stocks
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

Review 8.  Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  M Bradley Drummond; Elliott C Dasenbrook; Marshall W Pitz; David J Murphy; Eddy Fan
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

9.  Respiratory impairment in older persons: when less means more.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Gail McAvay; Philip H Quanjer; Peter H Van Ness; John Concato
Journal:  Am J Med       Date:  2012-11-20       Impact factor: 4.965

10.  Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study.

Authors:  Per Wollmer; Gunnar Engström
Journal:  Respir Med       Date:  2013-07-08       Impact factor: 3.415

View more
  1 in total

1.  Lost in interpretation: should the highest VC value be used to calculate the FEV1/VC ratio?

Authors:  Spyridon Fortis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.